The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - The FDA has two new drugs in its queue this morning after GlaxoSmithKline (NYSE:GSK) submitted two new melanoma treatments, dabrafenib and trametinib, to the U.S. … Continue Reading
Read now- Rosetta Genomics (NASDAQ:ROSG) tumbled after the company announced last night that it would be initiating a $27.5MM public offering. Shares are down 15% premarket and … Continue Reading
Read nowLong Ideas - Shares of MAKO Surgical (NASDAQ:MAKO) are moving up today, trading higher by roughly 5% after yesterday’s earnings report. In the last four months, MAKO tumbled … Continue Reading
Read nowLong Ideas - Incyte (NASDAQ:INCY) shares plummeted today after the company released its second quarter earnings report. Although the report showed top- and bottom-line growth, revenue generation came … Continue Reading
Read nowLong Ideas - ALK inhibitor crizotinib was approved last August under Pfizer’s (NYSE:PFE) marketing name Xalkori for the treatment of some forms of non-small cell lung cancer (NSCLC). … Continue Reading
Read now- Teva Pharmaceuticals (NASDAQ:TEVA) posted in-line Q2 earnings this morning, although TEVA is trading down 2%. With EPS of $1.28 and 19% revenue growth for the … Continue Reading
Read nowQuick Picks - With Gilead (NASDAQ:GILD) paying $11 billion for Pharmasset last year, the action around the next generation of hepatitis C treatments has centered on nucleoside type … Continue Reading
Read now
